Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Doxorubicin × 1 year × Clear all

Phase

Phase 2 102 Phase 3 82 Phase 1 29 Phase 1/2 27 Phase 2/3 10 Phase EARLY_PHASE1 4 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Dexamethasone 11 Fluorouracil 8 Carboplatin 8 Saline Solution 7 Human Papillomavirus Recombinant Vaccine nonavalent 7 Bupivacaine 7 pembrolizumab 6 anlotinib 6 Tobacco Use Cessation Devices 6 Magnetic Resonance Spectroscopy 6 Lenalidomide 6 Standard of Care 5 Specimen Handling 5 Propofol 5 Prednisone 5 Nivolumab 5 Cisplatin 5 Bortezomib 5 Bevacizumab 5 trametinib 4 lenvatinib 4 enzalutamide 4 dabrafenib 4 cabozantinib 4 Sodium Chloride 4 Ropivacaine 4 Rituximab 4 Paclitaxel 4 Imatinib Mesylate 4 Esomeprazole 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02688803 2025-12-04

OTT15-04

Ottawa Hospital Research Institute

Phase 4 Terminated

2 enrolled 4 charts

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡